Vivus Inc.

Latest Vivus Inc. Items
  • This product image provided by Vivus Pharmaceuticals Inc. shows bottles of Qsymia, the company's anti-obesity drug. (Associated Press/Vivus Pharmaceuticals Inc.)

    Highly anticipated weight-loss pill wins approval

    A new weight-loss pill that many doctors consider the most effective of a new generation of anti-obesity drugs got the approval of the Food and Drug Administration on Tuesday.


  • Highly anticipated weight-loss pill wins approval

    A new weight-loss pill that many doctors consider the most effective of a new generation of anti-obesity drugs got the approval of the Food and Drug Administration on Tuesday.


  • FDA approves highly anticipated weight-loss pill

    The Food and Drug Administration on Tuesday approved a new weight loss drug from Vivus Inc. that many doctors consider the most effective therapy in a new generation of anti-obesity pills designed to help patients safely shed pounds.


  • FDA raises safety concerns for Vivus diet pill

    Federal health officials say they still have safety concerns about an experimental diet pill from drugmaker Vivus Inc., as the company prepares to make a second attempt to convince experts of the drug's safety next week.


  • FDA panel recommends approval for Contrave

    A Food and Drug Administration panel on Tuesday recommended that the agency approve Orexigen Therapeutics Inc.'s weight loss drug Contrave, making it the first in group of competitors to get a positive nod from experts.


  • FDA panel recommends approval for Contrave

    A Food and Drug Administration panel on Tuesday recommended that the agency approve Orexigen Therapeutics Inc.'s weight loss drug Contrave, making it the first in group of competitors to get a positive nod from experts.


  • FDA panel rejects experimental weight loss pill

    A panel of federal health experts dealt a surprising setback Thursday to a highly anticipated anti-obesity pill from Vivus Inc., saying the drug's side effects outweigh its ability to help patients lose weight.


  • FDA to review first of 3 new weight loss drugs

    Dieters, doctors and investors get their first extensive look at the first of a trio of new weight loss drugs this week. The hope is that the new drugs can succeed where many others have failed: delivering significant weight loss without risky side effects.


  • FDA to review first of 3 new weight loss drugs

    Dieters, doctors and investors get their first extensive look at the first of a trio of new weight loss drugs this week. The hope is that the new drugs can succeed where many others have failed: delivering significant weight loss without risky side effects.


Happening Now